Jack W. Callicutt
2013
In 2013, Jack W. Callicutt earned a total compensation of $853.9K as Chief Financial Officer at Galectin Therapeutics.
Compensation breakdown
| Bonus | $39,803 |
|---|---|
| Option Awards | $709,542 |
| Salary | $87,500 |
| Other | $17,074 |
| Total | $853,919 |
Callicutt received $709.5K in option awards, accounting for 83% of the total pay in 2013.
Callicutt also received $39.8K in bonus, $87.5K in salary and $17.1K in other compensation.
Rankings
In 2013, Jack W. Callicutt's compensation ranked 7,327th out of 12,286 executives tracked by ExecPay. In other words, Callicutt earned more than 40.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,327 out of 12,286 | 40th |
Division Manufacturing | 2,629 out of 4,612 | 43rd |
Major group Chemicals And Allied Products | 821 out of 1,466 | 44th |
Industry group Drugs | 618 out of 1,160 | 47th |
Industry Pharmaceutical Preparations | 486 out of 890 | 45th |
Source: SEC filing on November 10, 2016.
Callicutt's colleagues
We found three more compensation records of executives who worked with Jack W. Callicutt at Galectin Therapeutics in 2013.